0000905718-17-000008.txt : 20170104 0000905718-17-000008.hdr.sgml : 20170104 20170104172601 ACCESSION NUMBER: 0000905718-17-000008 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 EFFECTIVENESS DATE: 20170104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zomedica Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001684144 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-277630 FILM NUMBER: 17507128 BUSINESS ADDRESS: STREET 1: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734)369-2555 MAIL ADDRESS: STREET 1: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 D 1 primary_doc.xml X0707 D LIVE 0001684144 Zomedica Pharmaceuticals Corp. 3928 VARSITY DRIVE ANN ARBOR MI MICHIGAN 48108 (734) 369-2555 ALBERTA, CANADA Wise Oakwood Ventures Inc. None Corporation true 2013 Gerald Solensky 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Executive Officer Director William MacArthur 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Executive Officer Director Jim Lebar 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Director Stephanie Morley 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Executive Officer Shameze Rampertab 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Executive Officer Director Jeffrey Rowe 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Director Rodney J. Williams 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Director Tom Robitaille 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Director Jane Eagleson 3928 Varsity Drive Ann Arbor MI MICHIGAN 48108 Director Pharmaceuticals Decline to Disclose 06b false 2016-12-29 false true false 0 7389740 866000 6523740 U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on December 29, 2016, which wasCdn$1.3488=US$1.00. Actual exchange rates will be specific to dates of closing. Excludes sales to offshore investors. false 3 0 0 0 true Some of the proceeds may be used for general working capital purposes, including the payment of salaries and other fees to those listed in Item 3. false Zomedica Pharmaceuticals Corp. /s/ Gerald Solensky Gerald Solensky President & Chief Executive Officer 2017-01-04